What should you know about CAR T cell therapy as a myeloma treatment? Dr. Beth Faiman, a myeloma expert and researcher, will discuss factors that should be considered when deciding to undergo CAR T-cell therapy, advice for preparing for and after the process, and why a good support team is essential. Dr. Faiman will also share research updates in CAR T-cell therapy, and alternatives options to this myeloma therapy.
Register today to watch online on Tuesday, March 12 at 1 PM Eastern (10 AM PT, 12 PM CT) for a 30-minute webinar and download the resource guide before the webinar airs.
The webinar will be recorded. If you would like to share it with others, the replay will be available within the next few days. To receive a link to the recording, please register and you will be notified when it’s available.
I'll be at the March 12th Thrive | Considering CAR T-Cell Therapy for Myeloma? What You Should Know webinar. Join me! Click To TweetGuest
Advocacy Partners
 |
 |
 |
 |
 |
 |
This program is brought to you by the Patient Empowerment Network. It is sponsored by Janssen Oncology and Legend Biotech, and through generous donations from people like you.
